Skip to content


年 : 2021

日期 标题
2021-4-5 Illumina Announces Preliminary Revenue for First Quarter Fiscal Year 2021
2021-3-30 Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
2021-3-18 Illumina Announces Board Changes
2021-3-11 Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women
2021-3-5 Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia
2021-2-11 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2020
2021-2-10 Illumina to Webcast Upcoming Investor Conference Presentations
2021-2-8 Illumina加速器在第二轮全球周期中投资了9家基因组初创公司
2021-2-4 Illumina支持在比利时真实环境下评估全景变异分析在晚期癌症中应用潜力的国家级项目
2021-1-31 因美纳与红杉中国在华共推基因组学孵化器
2021-1-25 Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021
2021-1-20 Illumina Wins Patent Infringement Suit against BGI in the UK
2021-1-16 因美纳NextSeq™550Dx基因测序仪正式上市并完成首台装机
2021-1-11 全新生物信息解决方案将推动大规模多组学研究探索
2021-1-11 因美纳宣布与多家肿瘤领域企业达成全新合作 将推动全面基因组测序分析
2021-1-5 Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure